Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy
Busulfan and Melphalan Conditioning in Multiple Myeloma
Collection of Transplant Stem Cells for Plasma Cell Myeloma
Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients
VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
† Indicates status has not been verified in more than two years